Cardiosense

Cardiosense is a Chicago-based medical technology company that's fundamentally changing how heart disease is detected, monitored, and managed. Founded by engineers and scientists who have been developing the underlying technologies for more than a decade, the company leverages wearable technology, signal processing, and deep learning to diagnose and assess cardiovascular disease.

The company's flagship solution, CardioTag, is a multi-parameter wearable sensor device that has received FDA authorization. Combined with their PCWP Analysis Software, Cardiosense provides the first and only noninvasive heart failure monitoring solution that determines Pulmonary Capillary Wedge Pressure at point-of-care. This breakthrough technology enables clinicians to more precisely and proactively manage their heart failure patients, potentially reducing hospitalizations and improving long-term outcomes.

Cardiosense has developed an advanced AI platform that converts raw physiological waveform data into clinical intelligence, developing predictive biomarkers to identify at-risk patients and enable personalized therapy. The company has received FDA Breakthrough Device Designation and De Novo classification, validating their innovative approach to cardiac monitoring.